Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland

11. Literatur 221
336. Reynolds HE, Poon CM, Goulet RJ, Lazaridis CL. Biopsy of breast microcalcifications
using an 11-gauge directional vacuum-assisted device. AJR 1998;171:611–3.
337. Reynolds P, Hurley S, Torres M, Jackson J, Boyd P, Chen V. Use of coping strategies and
breast cancer survival: result from the black/white cancer survival study. Am J
Epidemiol 2000;152:940–9.
338. Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistic Review, 1973–1996.
National Cancer Institute. Bethesda, Maryland, USA 1999.
339. Rimer B, Bluman LG. The psychosocial consequences of mammography. J Natl Cancer
Inst Monogr 2002;22:131–8.
340. Rissanen T, Pamilo M, Suramo I. Ultrasonography as a guidance method in the
evaluation of mammographically detected nonpalpable breast lesions of suspected
malignancy. Acta Radiologica 1998;39:292–7.
341. Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast
cancer: mortality at seven years. Lancet 1990;335:241–6.
342. Robson M, Gilewski T, Haas B, et al. BRCA-associated breast cancer in young women.
J Clin Oncol 1998;16:1642–9.
343. Rogers EM. Innovativeness and adopter categories. In: Diffusion of Innovations. Free
Press, San Francisco 1995.
344. Rosen P, Synder S, Robbins G. Specimen radiography for nonpalpable breast lesions
found by mammography: procedures and results. Cancer 1974;34:2028–33.
345. Rosen PP. Rosen’s Breast Pathology. 1st ed.Philadelphia, Lippincott-Raven 1997.
346. Rosen PP, Groshen S, Saigo PE, et al. A long term follow-up study of survival in stage I
and stage II breast carcinoma. J Clin Oncol 1989;7:355–66.
347. Rosen PP, Oberman HA. Tumors of the mammary gland (vol Fasc.7). 3rd
ser.ed.Washington D.C., AFIP 1993.
348. Royal New Zealand College of General Practitioners (RNZCGP). Early detection of
breast cancer. 1999. Wellington, New Zealand: 1999:1–61.
349. Rubin E, Mennemeyer S, Desmned R, Urist M, Waterbor J, Hersin M et al. Reducing
the Cost of Diagnosis of Breast Carcinoma. Cancer 2001;91:324–32.
350. Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen.
Bedarfsgerechtigkeit und Wirtschaftlichkeit. 2001;Bd. I; Bd. II:11;47–45;96.
351. Sainsbury R, Haward B, Rider L, Joston C, Round C. Influence of clinician workload
and patterns of treatment on survival from breast cancer. Lancet 1995;345:
1265–70.
352. Sarfati MR, Fox KA, Warneke JA. Stereotactic fine-needle aspiration cytology of
nonpalpable breast lesions: an analysis of 258 consecutive aspirates. Am J Surg
1994;168:529–31.
353. Schmidt RA, Newstead GM, Linver MN, Winkler MA, Metz CE, Nishikawa RM.
Mammographic Sreening Sensitivity of General Radiologists: Effect of Double
Reading. Radiology 1998;209:392.
354. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of
resection and the risk of local recurrence in patients with breast cancer treated with
breast-conserving surgery and radiation therapy. Cancer 1994;74:1746-51.
355. Schnitt SJ, Wang HH. Histologic sampling of grossly benign breast biopsies: how much
is enough? Am J Surg Pathol 1989;13:505–12.
356. Schreer I, Frischbier HJ. Breast Cancer Screening Projects: Results. In: Radiological
Diagnosis of Breast Disease, ed.: M. Friedrich, E.A. Sickles 1997;333–46.
357. Schulz-Wendtland R, Aichinger U, Krämer S, Lang N, Bautz W. Mammographisch/
stereotaktisch gezielte Vakuum-/Exzisionsbiopsie. Radiologe 2001;41:379–84.
358. Schulz-Wendtland R, Bauer M, Auer M, Krämer S, Büttner A, Lang N. Stereotaxie –
Eine Methode zur Punktion, Stanzbiopsie und Markierung kleinster mammographischer
Herdbefunde. Gyn Prax 1994;18:505–18.